TS Alfrecca

TS Alfresa Corporation is a leading pharmaceutical wholesaler based in Hiroshima, Japan, and a wholly-owned subsidiary of Alfresa Holdings Corporation. The company specializes in the distribution of ethical pharmaceuticals, medical devices, and diagnostic reagents, primarily serving the Chugoku region. Formed in 2015 through the merger of Seiwa Sangyo and Tokiwa Yakuhin, TS Alfresa plays a critical role in the regional healthcare infrastructure by providing total supply chain services to hospitals, clinics, and pharmacies. The company is actively expanding its capabilities in the medical device and veterinary sectors, highlighted by its 2025 acquisition and subsequent merger of Miyanomedix Inc.